Universitaire Du Cancer de Toulouse Institut Claudius Regaud Iuct-Oncopole

Toulouse 31059

2 studies enrolling now · 7 studies all time

What they study most

Adult-type Diffuse Gliomas, Bladder Cancer, Castration Resistant Prostate Cancer, Chronic Graft-versus-host-disease, Colorectal Cancer, Gastric/ Gastroesophageal Junction, Glioblastoma, Hepatocellular Carcinoma, Locally Advanced Solid Tumors, MPN (Myeloproliferative Neoplasms), Metastatic Solid Tumors, Non Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
• A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation — Recruiting now
• Study of INCB123667 in Subjects With Advanced Solid Tumors — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203) — Completed
• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — Completed
• INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors — Completed